HCAL
XENE icon

HURRICANE CAPITAL ADVISORS LLC’s Xenon Pharmaceuticals XENE Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,953
Closed -$352K – 721
2024
Q3 		$352K Buy
8,953
+500
+6% +$20.2K 0.12% 134
2024
Q2 		$330K Sell
8,453
-4,620
-35% -$185K 0.12% 138
2024
Q1 		$563K Sell
13,073
-4,500
-26% -$207K 0.16% 94
2023
Q4 		$809K Buy
+17,573
New +$621K 0.31% 49

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Braidwell
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Commodore Capital
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's XENE Position: Q4 2024 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of Xenon Pharmaceuticals (XENE) in Q4 2024, closing a stake of 8,953 shares — an estimated $352K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in XENE in Q4 2023 and held it in 4 quarters. The position peaked at $809K in Q4 2023. 211 funds tracked by Wall St. Rank hold XENE as of Q4 2024.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining Xenon Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 8,953 Xenon Pharmaceuticals shares in Q4 2024, an estimated $352K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Xenon Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • HURRICANE CAPITAL ADVISORS LLC's Xenon Pharmaceuticals position peaked at $809K in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2024.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q4 2024, filed 3 Nov 2026.